Compounds > oseltamivir
Page last updated: 2024-08-24

oseltamivir and Critical Illness

oseltamivir has been researched along with Critical Illness in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (2.27)29.6817
2010's35 (79.55)24.3611
2020's8 (18.18)2.80

Authors

AuthorsStudies
Bodí, M; Canadell, L; Carbonell, R; Correig, E; Díaz, E; Guardiola, J; Marín-Corral, J; Martín-Loeches, I; Moreno, G; Papiol, E; Restrepo, MI; Reyes, LF; Rodríguez, A; Socias, L; Solé-Violán, J; Trefler, S; Vidaur, L1
Benken, LA; Kaplan, JM; Krallman, KA; Mizuno, T; Stoneman, EM; Tang Girdwood, SC; Vinks, AA; Wong, HR; Yunger, TM1
Cao, B; Chen, C; Fan, G; Guo, L; Hayden, FG; Horby, P; Lu, B; Pan, J; Salam, A; Wang, C; Wang, Y; Zheng, J1
Eltorki, M; Sharif, S1
Arabi, YM; Fowler, R; Hayden, FG1
Martin-Loeches, I; O'Sullivan, S; Rodriguez, A; Torres, A1
Fujishima, S1
Slain, D1
Brady, J; Fetters, M; Francisco, J; Kim, C; MacLaren, R; Welker, C1
Ahmed, JJ; Constable, JD; De, M; Kamani, T1
Argaud, L; Casalegno, JS; Chroboczek, T; Cour, M; Hernu, R; Lina, B; Madelaine, T1
Favié, LM; Meijer, A; Murk, JL; Nijstad, AL; Sikma, MA; van Maarseveen, EM1
Andreopoulou, A; Bonovas, S; Lytras, T; Mouratidou, E; Tsiodras, S1
Alfayate, S; Couceiro, JA; Cruz-Cañete, M; Launes, C; Otheo, E; Pérez, C; Tagarro, A1
Ala-Kokko, T; Herwald, H; Kaukonen, KM; Lindbom, L; Linko, R; Pettilä, V; Ruokonen, E1
Beijnen, JH; de Lange, DW; Huitema, AD; Kromdijk, W; Sikma, MA; van den Broek, MP1
Louie, JK; Samuel, MC; Schechter, R; Uyeki, TM; Yang, S1
Norris, A; Sandrock, CE1
Burleigh, L; Chappey, C; Giraudon, M; Várkonyi, I1
Choi, SH; Hong, SB; Huh, JW; Koh, Y; Lim, CM; Yoo, JW1
Ferda, K; Guven, O; Halis, A; Ilker, C; Meltem, OT; Nermin, KG; Remzi, I; Zeynep, A1
Bastin, MLT; Flannery, AH; Montgomery, AA; Noel, ZR1
Fowler, R; Jones, M1
Franquiz, MJ; Gonzales, JP; Saleeb, PG; Shanholtz, CB1
Ahern, S; Ariano, RE; Kanji, S; Kumar, A; Pisipati, A; Rello, J; Sitar, DS; Zarychanski, R; Zelenitsky, SA1
Chappell, JD; Creech, CB; Denison, MR; Domm, J; Dulek, DE; Frangoul, HA; Schulert, AK; Williams, JV1
Avery, L; Kumar, A; Lapinsky, S; Menticoglou, S; Oluyomi-Obi, T; Schneider, C; Zarychanski, R1
Ahsman, MJ; de Hoog, M; Fraaij, PL; Osterhaus, AD; Tibboel, D; Wildschut, ED1
Chappuy, H; Duchêne, P; Ducrocq, S; Giraud, C; Hubert, P; Manceau, S; Mogenet, A; Oualha, M; Treluyer, JM1
Godara, SM; Goplani, KR; Gumber, MR; Kute, VB; Shah, PR; Shah, VR; Trivedi, HL; Vanikar, AV1
Ellermann-Eriksen, S; Gubbels, S; Ilkjær, S; Jensen-Fangel, S; Keld, DB; Lindskov, C; Petersen, E1
Al-Hegelan, MS; Cheifetz, IM; Noble, PW; Ozment, CP; Peters, MA; Peterson-Carmichael, SL; Rehder, KJ; Turner, DA; Williford, WL1
Alvarez-Lerma, F; Baladín, B; Blanquer, J; Bonastre, J; Canadell, L; Díaz, E; Díaz, JJ; Figueira, JC; García-López, F; Marques, A; Martín-Loeches, I; Rello, J; Rodríguez, A; Sandiumenge, A; Suberviola, B; Trefler, S; Vallés, J; Zaragoza, R1
Kumar, A1
Hobson, MJ; Morgan, CI; Rice, MA; Seger, B; Staat, MA; Wheeler, DS1
Beersma, MF; Boucher, CA; de Jong, MD; Fouchier, RA; Fraaij, PL; Horrevorts, AM; Houmes, RJ; Koopmans, MP; Kroes, AC; Niesters, HG; Osterhaus, AD; Reis Miranda, D; Ridwan, BU; Riezebos-Brilman, A; van der Eijk, AA; van der Vries, E; van Dissel, JT; Wolfhagen, MJ1
Choi, SH; Chon, GR; Han, MS; Hong, SB; Huh, JW; Kim, HR; Kim, MJ; Kim, SH; Kim, WY; Kim, YS; Ko, YG; Lee, KH; Ryu, YJ; Young Suh, G1
Coffin, SE; Hall, M; Keren, R; Leckerman, K; Localio, R; Zaoutis, TE1
Ala-Kokko, T; Karlsson, S; Linko, R; Parviainen, I; Perttilä, J; Pettilä, V; Reinikainen, M; Ruokonen, E; Saarinen, K; Tenhunen, J; Varpula, T1
Antignac, M; Combes, A; Corvol, E; Farinotti, R; Fernandez, C; Lemaitre, F; Luyt, CE; Nieszkowska, A; Roullet-Renoleau, F; Zahr, N1
Eun, BW; Hong, JY; Kang, JH; Kim, JH; Kim, KH; Ko, JH; Oh, SH1
Eyler, RF; Heung, M; Mueller, BA; Napolitano, LM; Park, PK; Pleva, M; Sowinski, KM1
Harvey, C; Kidy, Z; Mulla, H; Peek, GJ; Ramaiah, R; Westrope, C1
Ahmed, QA; Arabi, Y; Boynton, BR; Gomersall, CD; Memish, ZA1

Reviews

6 review(s) available for oseltamivir and Critical Illness

ArticleYear
Critical care management of adults with community-acquired severe respiratory viral infection.
    Intensive care medicine, 2020, Volume: 46, Issue:2

    Topics: Adult; Antiviral Agents; Community-Acquired Infections; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Evidence-Based Medicine; Humans; Influenza, Human; Intensive Care Units; Macrolides; Noninvasive Ventilation; Oseltamivir; Pneumonia; Pneumonia, Viral; Respiration, Artificial; Severe Acute Respiratory Syndrome; Severity of Illness Index

2020
Influenza management with new therapies.
    Current opinion in pulmonary medicine, 2020, Volume: 26, Issue:3

    Topics: Adrenal Cortex Hormones; Amides; Antiviral Agents; Critical Care; Critical Illness; Dibenzothiepins; Enzyme Inhibitors; Humans; Influenza, Human; Morpholines; Neuraminidase; Oseltamivir; Pyrazines; Pyridines; Pyridones; Pyrimidines; Pyrroles; Respiration, Artificial; Triazines; Zanamivir

2020
[Oseltamivir for the treatment of influenza in children and adolescents].
    Anales de pediatria, 2019, Volume: 90, Issue:5

    Topics: Adolescent; Age Factors; Antiviral Agents; Child; Critical Illness; Humans; Influenza, Human; Oseltamivir; Risk Factors; Time Factors

2019
Infection in severe asthma exacerbations and critical asthma syndrome.
    Clinical reviews in allergy & immunology, 2015, Volume: 48, Issue:1

    Topics: Animals; Asthma; Azithromycin; Bacterial Infections; Ceftriaxone; Coinfection; Critical Illness; Disease Progression; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Seasons; Syndrome

2015
Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5

    Topics: Antiviral Agents; Critical Illness; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Survival Analysis; Time Factors; Treatment Outcome

2011
The critically ill avian influenza A (H5N1) patient.
    Critical care medicine, 2007, Volume: 35, Issue:5

    Topics: Antiviral Agents; Critical Illness; Humans; Infection Control; Influenza A Virus, H5N1 Subtype; Influenza, Human; Multiple Organ Failure; Oseltamivir; Prognosis; Respiratory Distress Syndrome; Reverse Transcriptase Polymerase Chain Reaction

2007

Trials

2 trial(s) available for oseltamivir and Critical Illness

ArticleYear
A part-randomized study of intravenous oseltamivir in adolescents and adults.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Blood Chemical Analysis; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Influenza, Human; Infusions, Intravenous; Male; Middle Aged; Nasal Mucosa; Oseltamivir; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Virus Cultivation; Virus Shedding; Young Adult

2015
Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support.
    Anaesthesia and intensive care, 2013, Volume: 41, Issue:1

    Topics: Adult; Antiviral Agents; Area Under Curve; Creatinine; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nonlinear Dynamics; Oseltamivir; Tissue Distribution

2013

Other Studies

36 other study(ies) available for oseltamivir and Critical Illness

ArticleYear
Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study.
    Journal of medical virology, 2023, Volume: 95, Issue:8

    Topics: Adult; Antiviral Agents; Critical Illness; Humans; Influenza, Human; Oseltamivir; Retrospective Studies

2023
Route of Oseltamivir Administration Affects Metabolite Concentrations in Critically Ill Children.
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:12

    Topics: Administration, Oral; Adolescent; Antiviral Agents; Area Under Curve; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Influenza, Human; Intubation, Gastrointestinal; Male; Oseltamivir; Prospective Studies; Young Adult

2019
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection.
    The Journal of infectious diseases, 2020, 04-27, Volume: 221, Issue:10

    Topics: Aged; Amides; Antiviral Agents; Critical Illness; Drug Therapy, Combination; Female; Humans; Influenza, Human; Male; Middle Aged; Oseltamivir; Pyrazines; Retrospective Studies

2020
Massive air leak secondary to influenza B in a 7-year-old: A case report.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:5

    Topics: Antiviral Agents; Child; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome

2020
COVID-19: Stay Cool toward Corticosteroids.
    The Keio journal of medicine, 2020, 06-25, Volume: 69, Issue:2

    Topics: Adrenal Cortex Hormones; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza.
    The Annals of pharmacotherapy, 2021, Volume: 55, Issue:6

    Topics: Antiviral Agents; Critical Illness; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir

2021
Oseltamivir-Associated Bradycardia in Critically Ill Patients.
    The Annals of pharmacotherapy, 2021, Volume: 55, Issue:11

    Topics: Adult; Antiviral Agents; Bradycardia; Critical Illness; Humans; Influenza, Human; Oseltamivir; Retrospective Studies

2021
Multipathogenic necrotising supraglottitis in an immunocompetent patient.
    BMJ case reports, 2017, Jun-18, Volume: 2017

    Topics: Adult; Anti-Bacterial Agents; Critical Illness; Debridement; Enterococcus faecalis; Haemophilus Infections; Haemophilus influenzae type b; Humans; Immunocompetence; Influenza A virus; Influenza, Human; Male; Necrosis; Oseltamivir; Penicillin G; Supraglottitis; Tracheostomy; Treatment Outcome

2017
Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis.
    Intensive care medicine, 2018, Volume: 44, Issue:2

    Topics: Aged; Antiviral Agents; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Treatment Outcome

2018
Pharmacokinetics of favipiravir during continuous venovenous haemofiltration in a critically ill patient with influenza.
    Antiviral therapy, 2018, Volume: 23, Issue:5

    Topics: Amides; Antiviral Agents; Critical Illness; Fatal Outcome; Hemofiltration; Humans; Influenza, Human; Intensive Care Units; Male; Middle Aged; Netherlands; Oseltamivir; Pyrazines; Tertiary Care Centers

2018
Effect of Early Oseltamivir Treatment on Mortality in Critically Ill Patients With Different Types of Influenza: A Multiseason Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-13, Volume: 69, Issue:11

    Topics: Adult; Aged; Antiviral Agents; Critical Illness; Female; Humans; Influenza, Human; Intensive Care Units; Male; Middle Aged; Oseltamivir; Survival Analysis; Young Adult

2019
Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:12

    Topics: Adult; Antimicrobial Cationic Peptides; Antiviral Agents; Blood Proteins; Carrier Proteins; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Prospective Studies; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Shock, Septic

2013
Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique.
    Intensive care medicine, 2013, Volume: 39, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics

2013
Neuraminidase inhibitors for critically ill children with influenza.
    Pediatrics, 2013, Volume: 132, Issue:6

    Topics: Acids, Carbocyclic; Adolescent; Betainfluenzavirus; California; Child; Child, Preschool; Critical Care; Critical Illness; Cyclopentanes; Drug Administration Schedule; Enzyme Inhibitors; Guanidines; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Logistic Models; Multivariate Analysis; Neuraminidase; Odds Ratio; Oseltamivir; Pandemics; Population Surveillance; Treatment Outcome; Zanamivir

2013
Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
    Journal of medical virology, 2015, Volume: 87, Issue:10

    Topics: Acids, Carbocyclic; Administration, Oral; Adult; Aged; Aged, 80 and over; Antiviral Agents; Critical Illness; Cyclopentanes; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Middle Aged; Organ Dysfunction Scores; Oseltamivir; Retrospective Studies; Seasons; Time Factors; Treatment Outcome; Young Adult

2015
A retrospective evaluation of critically ill patients infected with H1N1 influenza A virus in Bursa, Turkey, during the 2009-2010 pandemic.
    African health sciences, 2015, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; APACHE; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Retrospective Studies; Turkey; Young Adult

2015
Comparison of High-Dose Versus Standard Dose Oseltamivir in Critically Ill Patients With Influenza.
    Journal of intensive care medicine, 2017, Volume: 32, Issue:10

    Topics: Adult; Aged; Antiviral Agents; APACHE; Critical Illness; Dose-Response Relationship, Drug; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza, Human; Intensive Care Units; Length of Stay; Male; Middle Aged; Oseltamivir; Respiration, Artificial; Retrospective Studies; Time Factors; Treatment Outcome

2017
Immortal time bias in observational studies of time-to-event outcomes.
    Journal of critical care, 2016, Volume: 36

    Topics: Antiviral Agents; Bias; Computer Simulation; Critical Illness; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Logistic Models; Observational Studies as Topic; Oseltamivir; Proportional Hazards Models; Survival Analysis; Time Factors

2016
Clinical characteristics of critically ill patients with suspected influenza during the 2009-10 and 2013-14 outbreaks.
    Journal of critical care, 2017, Volume: 38

    Topics: Antiviral Agents; APACHE; Cohort Studies; Critical Care; Critical Illness; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Maryland; Middle Aged; Oseltamivir; Retrospective Studies

2017
Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Mar-09, Volume: 182, Issue:4

    Topics: Adolescent; Adult; Antiviral Agents; Critical Illness; Disease Outbreaks; Drug Administration Schedule; Female; Gastrointestinal Tract; Half-Life; Humans; Influenza, Human; Intensive Care Units; Kidney; Male; Oseltamivir; Tandem Mass Spectrometry; Young Adult

2010
Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jun-01, Volume: 50, Issue:11

    Topics: Antiviral Agents; Compassionate Use Trials; Critical Illness; Drug Resistance, Viral; Female; Humans; Immunocompromised Host; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Injections, Intravenous; Oseltamivir; Treatment Outcome; Viral Load; Zanamivir

2010
Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2010, Volume: 32, Issue:5

    Topics: Abortion, Spontaneous; Adolescent; Adult; Antiviral Agents; Critical Illness; Disease Outbreaks; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Manitoba; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Respiration, Artificial

2010
Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
    PloS one, 2010, Jun-03, Volume: 5, Issue:6

    Topics: Adolescent; Antiviral Agents; Area Under Curve; Child; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Oseltamivir; Prospective Studies

2010
High levels and safety of oseltamivir carboxylate plasma concentrations after nasogastric administration in critically ill children in a pediatric intensive care unit.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Influenza, Human; Intensive Care Units; Intubation, Gastrointestinal; Male; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction

2011
High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:1

    Topics: Acute Kidney Injury; Adolescent; Adult; Antiviral Agents; APACHE; Critical Illness; Female; Humans; India; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Multiple Organ Failure; Oseltamivir; Pandemics; Pneumonia, Viral; Renal Replacement Therapy; Respiration, Artificial; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult

2011
Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:6-7

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Antiviral Agents; Child; Critical Illness; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Respiration, Artificial; Time Factors; Treatment Failure; Virus Shedding; Zanamivir

2011
Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.
    Respiratory care, 2011, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Antiviral Agents; Child; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units, Pediatric; Male; Oseltamivir; Respiratory Insufficiency; Retrospective Studies; Young Adult; Zanamivir

2011
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5

    Topics: Adult; Antiviral Agents; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Prospective Studies; Time Factors; Treatment Outcome

2011
2009 pandemic influenza A (H1N1) in critically ill children in Cincinnati, Ohio.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2012, Volume: 13, Issue:3

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Critical Care; Critical Illness; Female; Hospitalization; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units, Pediatric; Male; Ohio; Oseltamivir; Pandemics; Respiratory Therapy; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2012
Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.
    The Journal of infectious diseases, 2011, Sep-01, Volume: 204, Issue:5

    Topics: Adolescent; Adult; Child, Preschool; Critical Illness; Drug Therapy, Combination; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Infusions, Intravenous; Middle Aged; Netherlands; Oseltamivir; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load; Zanamivir

2011
Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Cohort Studies; Critical Illness; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Korea; Male; Middle Aged; Oseltamivir; Pandemics; Respiration, Artificial; Retrospective Studies; Ribavirin; Treatment Outcome

2011
Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:11

    Topics: Antiviral Agents; Child, Hospitalized; Child, Preschool; Critical Illness; Databases, Factual; Female; Hospital Mortality; Hospitalization; Hospitals, Pediatric; Humans; Infant; Influenza, Human; Intensive Care Units, Pediatric; Length of Stay; Male; Orthomyxoviridae; Oseltamivir; Retrospective Studies; Treatment Outcome; United States

2011
Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland.
    Acta anaesthesiologica Scandinavica, 2011, Volume: 55, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Critical Care; Critical Illness; Data Collection; Female; Finland; Hospital Mortality; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Middle Aged; Multiple Organ Failure; Oseltamivir; Polymerase Chain Reaction; Prospective Studies; Respiratory Distress Syndrome; Respiratory Mechanics; Young Adult

2011
Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:2

    Topics: Acute Kidney Injury; Adult; Antiviral Agents; Area Under Curve; Critical Illness; Dose-Response Relationship, Drug; Extracorporeal Membrane Oxygenation; Female; Hemodiafiltration; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pandemics; Respiratory Distress Syndrome; Young Adult

2012
Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea.
    Journal of Korean medical science, 2012, Volume: 27, Issue:4

    Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Critical Illness; Dyspnea; Female; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphopenia; Male; Oseltamivir; Pandemics; Republic of Korea; Retrospective Studies

2012
Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Pharmacotherapy, 2012, Volume: 32, Issue:12

    Topics: Academic Medical Centers; Adolescent; Adult; Antiviral Agents; Area Under Curve; Critical Illness; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Prospective Studies; Renal Dialysis; Time Factors

2012